Lans Holdings Inc (fka LAHO)

[ApollyonZ]

$LAHO..Global Stem Centers..36 worldwide in 27 countries 41 by Nov-19 and Shiller Valuation.

Lans Holdings, Inc.

Our Email is:[e-mail]
[e-mail]
[e-mail]
[e-mail]

For further information, please contact:
Telephone: [phone] and 305-755-7451

https://www.otcmarkets.com/stock/LAHO/disclosure

..(GSCG)..binding letter..to sell 100% to Lans Holdings Inc. (OTCPink: LAHO)
https://www.stemcellsgroup.com/lans-holdings-enters-into-binding-loi-to-acquire-global-stem-cells-group/

SEC filed.. penalty of $500,000 for the party that breaches terms of the binding LOI.


https://www.otcmarkets.com/filing/html?id=13457482&guid=XsnyU6JxIB4yuyh

$29M Zoominfo
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775

We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.

http://www.stemcellsgroup.com/adimarket-launches-website/

..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians

http://stemcellcenter.net/



..upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html

Global Stem..Market to Reach US$ 467 billion by 2024 ..Due to the increased funding from Government and Private sector and rising global awareness.

https://www.marketwatch.com/press-release/global-stem-cells-market-is-determined-to-reach-us-467-billion-by-2024-2019-03-05

The Shiller P/E is a more reasonable market valuation indicator than the P/E ratio because it eliminates fluctuation of the ratio caused by the variation of profit margins during business cycles.

Sector Healthcare: 30.50
Sector Texhnology: 34.40

https://www.gurufocus.com/shiller-PE.php
http://www.econ.yale.edu/~shiller/

BioTechnology VS..


https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503


Studies a U.S. FDA-regulated Device Product: YES

Estimated Study Start Date : May 13, 2019
Estimated Primary Completion Date : September 15, 2020
Estimated Study Completion Date : November 1, 2020
https://clinicaltrials.gov/ct2/show/NCT03752827

Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/

GSCG ISSCA Launch Dates.

•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212

LAHO!..CEO Announces..New Stem Cell Center in Valencia, Spain

..“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”


https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1376239
[color=red]

Global Stem Cells Group has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city.

Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/

Novas’ travel took him to Dubai, Oman and Kuwait where he met with investors and learned more about medical regulations in the region.

https://www.kuam.com/story/40113402/global-stem-cells-group-visits-middle-east-in-effort-to-expand-access-to-regenerative-medicine



....“Our objective is to bring this cutting-edge3D bioprinting technology to scientists and regenerative medicine researcher..





https://www.facebook.com/pg/globalstemcells/photos/?ref=page_internal

LAHO CEO Dave Christensen highly skilled.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149320841

..ISSCA Set to Host Regenerative Medicine Symposium in Buenos Aires
https://www.stemcellsgroup.com/

Adimarket featured products!

Magellan PRP The Magellan® technology
32” Portable Clean Room $4,500.00
INKREDIBLE 3D BIOPRINTER

BEAR C2202 Centrifuge $3,000.00
Shockwave Machine $3,500.00
H.I.F.U High Intensity Focused Ultrasound $7,500.00

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149417821
https://www.adimarket.net/product-category/in-office-processing-equipment/

Global Stem Cells Group CEO Benito Novas is driven by his passion for helping physicians and scientists change the world through stem cell medicine. Dedicated to creating critical organizational systems that ensure success, he is an expert in the field of specialized marketing focused on Biotechnology, Life Sciences, and Healthcare development.
http://www.stemcellsgroup.com/management/

Global Stem Cells Group’s Benito Novas Announces Agreement with Clinica Planas

..The ongoing partnership will offer certification in regenerative medicine for European-based medical practitioners .

https://www.stemcellsgroup.com/benito-novas-announces-agreement-with-clinica-
https://cursocelulasmadre.com/entrenamiento-en-

GSCG is #1 Competitor for Biostems Tech $1.52
Dark Defunct

GCSG is #1 competitor for Beike Biotechnology.

GSCG is #1 competitor of Global Institute Of Stem Cell Therapy And Research!


Facility And Equipment
http://stemcellslab.net/facility-and-equipment/

“Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health. “In many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive

Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149422974

http://www.stemcellsgroup.com/adimarket-launches-website/



..Bioheart, Inc. (otcqb:BHRT), a biotech company focused on the discovery, development and commercialization of autologous cell therapies, has announced that it has initiated a new clinical site in collaboration with Global Stem Cell Group in Cozumel, Mexico. The two companies have successfully treated their first congestive heart failure patient at the new clinical site last week using Bioheart's AdipoCell (adipose derived stem cells).

https://www.marketwatch.com/press-release/bioheart-announces-new-clinical-site-in-mexico-2013-11-25

Advancells ties up with Global Stem Cells Group
https://ehealth.eletsonline.com/2015/03/advancells-ties-global-stem-cells-group/amp/

Global Stem Cells Group and Kimera Labs Announce Autologous Stem Cell Research Alliance
https://www.streetinsider.com/dr/news.php?id=11539116

Global Stem Cells Group's Chile Facility Expected to Receive Regenetech RTA Certification
https://www.newswire.com/news/global-stem-cells-groups-chile-facility-expected-to-receive-regenetech-rta

Global Stem Cells Group to Host Stem Cells and Regenerative ...
ISSCA Physicians looking for new alternatives to improve the quality of life of their patients through emerging regenerative medicine protocols..

https://www.issca.us/stem-cells-and-regenerative-medicine-conference-in-miami/

Barcelona, Spain

J. Victor Garcia Gimenez, M.D. is president of Therapeutic Confrontations (CONFTERA), is a specialist in orthopedic surgery and practices cosmetic medicine and surgery, anti-aging medicine, and aesthetic therapies in Barcelona, Spain.


http://stemcellcenter.net/centers/spain/barcelona/barcelona-spain/\

ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center Belgium’s Churchill Aesthetic Center

....The cutting-edge facility will be equipped by Adimarket, LLC, a subsidiary of the Global Stem Cells Group. Adimarket will outfit the center with equipment and supplies designed to not only teach doctors about the latest protocols in regenerative medicine but also to treat patients suffering from degenerative diseases and sports injuries. Physicians training at the facility will have access to the proven expertise of ISSCA’s global network and training protocols.
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/



Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.


..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA

..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).

Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases. He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota.

Dr. Feinerman is a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.

http://www.stemcellsgroup.com/advisory-board/

State-Of-The-Art Equipment

We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients


http://stemcellcenter.net/programs/

GLTA


$LAHO GSCG